Form4insider filings, from the source

SEC Form 4 · accession 0001179110-15-004066

KYTHERA BIOPHARMACEUTICALS INC · KYTH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Keith R Leonard
Officer — President & CEO · Director
Period of report
Mar 2, 2015
Accepted (ET)
Mar 3, 2015 · 5:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001436304

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF7,F2Mar 2, 2015S6,561$40.1027D883,614ISee footnote
Common StockF8,F2Mar 2, 2015S1,314$41.5753D882,300ISee footnote
Common StockF9,F2Mar 2, 2015S2,150$42.4923D880,150ISee footnote
Common StockF10,F2Mar 2, 2015S600$43.10D879,550ISee footnote
Common StockF3holding———49,649ISee footnote
Common StockF4holding———49,649ISee footnote
Common StockF5holding———189ISee footnote
Common StockF6holding———189ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses